New product [Regulatives / Guidelines]

posted by Ohlbe – France, 2020-03-11 17:54 (318 d 12:41 ago) – Posting: # 21257
Views: 3,187

Dear SKM,

» Both the APIs are registered and marketed as separate formulation. We are mixing these two at same ratio into one formulation without adding any new excipients. I don't know why will it be considered as a new product. Can you guide me please?

Well, you are giving all the arguments yourself: up to now the two active substances are only marketed as separate formulations. You will be mixing them into one new formulation, which has never been tested or marketed before. Sorry, but I can't explain more.


Complete thread:

 Admin contact
21,310 posts in 4,445 threads, 1,489 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Sunday 06:35 CET (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz